|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.980 USD | -3.25% |
|
-.--% | -13.12% |
| 06-26 | HLS Therapeutics Inc. - Shareholder/Analyst Call | |
| 06-23 | HLS Therapeutics to Begin its Normal Course Issuer Bid | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HLS THERAPEUTICS INC. | Pharmaceuticals Wholesale | -3.25% | -.--% | -13.12% | -19.24% | -78.70% | 90.43M |
-
|
-
|
-
|
- Stock Market
- Stocks
- HLS Stock
- HLTRF Stock
- Charts HLS Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
